Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Solesence ( (SLSN) ) is now available.
On September 3, 2025, Solésence, Inc. announced significant leadership changes as part of its strategic transformation. Kevin Cureton was promoted to President and CEO, Laura Riffner was appointed CFO, and Jess Jankowski transitioned to Board Advisor until his retirement in November 2025. These changes follow Solésence’s rebranding and uplisting to Nasdaq, positioning the company for continued growth in delivering high-performance skincare products. The leadership appointments are expected to drive future innovation and growth, enhancing Solésence’s market position and shareholder value.
The most recent analyst rating on (SLSN) stock is a Hold with a $3.50 price target. To see the full list of analyst forecasts on Solesence stock, see the SLSN Stock Forecast page.
Spark’s Take on SLSN Stock
According to Spark, TipRanks’ AI Analyst, SLSN is a Neutral.
Solesence’s overall stock score is primarily impacted by its strong financial performance, despite cash flow challenges. The technical analysis suggests bearish momentum, and the high P/E ratio indicates potential overvaluation. The absence of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on SLSN stock, click here.
More about Solesence
Solésence, Inc. is a leader in scientifically-driven health care solutions across beauty and life science categories. The company focuses on redefining mineral-based sun protection by enhancing transparency, effectiveness, aesthetics, and wearability, allowing brands to integrate protection, prevention, and treatment technologies into daily use products.
Average Trading Volume: 149,757
Technical Sentiment Signal: Strong Buy
Current Market Cap: $255.8M
See more data about SLSN stock on TipRanks’ Stock Analysis page.